Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma

Saved in:
Bibliographic Details
Published in:IJU Case Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870659543423254528
collection WordPress RSS
FRELIP Feed Integration
container_title IJU Case Reports
description
discipline_display Urology, Nephrology and Andrology
discipline_facet Urology, Nephrology and Andrology
format Online Article
RSS Article
genre Journal Article
id rss_article:102574
institution FRELIP
journal_source_facet IJU Case Reports
last_indexed 2026-07-14T03:32:41.176Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
sub_discipline_display General
sub_discipline_facet General
subject_display Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
subject_facet Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
title A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
title_alt Un caso raro de encefalopatía sospechosa de origen inmunológico tras terapia con Pembrolizumab más Lenvatinib para carcinoma de células renales
Un cas rare d'encéphalopathie suspectée d'origine immunitaire suite à un traitement par pembrolizumab plus lenvatinib pour un carcinome rénal
Um Caso Raro de Encefalopatia Suspeita Imunorrelacionada Após Terapia com Pembrolizumabe Mais Lenvatinibe para Carcinoma de Células Renais
title_auth A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
title_es_txt Un caso raro de encefalopatía sospechosa de origen inmunológico tras terapia con Pembrolizumab más Lenvatinib para carcinoma de células renales
title_fr_txt Un cas rare d'encéphalopathie suspectée d'origine immunitaire suite à un traitement par pembrolizumab plus lenvatinib pour un carcinome rénal
title_full A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
title_fullStr A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
title_full_unstemmed A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
title_pt_txt Um Caso Raro de Encefalopatia Suspeita Imunorrelacionada Após Terapia com Pembrolizumabe Mais Lenvatinibe para Carcinoma de Células Renais
title_short A Rare Case of Suspected Immune‐Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma
title_sort a rare case of suspected immune‐related encephalopathy following pembrolizumab plus lenvatinib therapy for renal cell carcinoma
topic Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
url https://onlinelibrary.wiley.com/doi/10.1002/iju5.70227?af=R